150 related articles for article (PubMed ID: 32154662)
81. MiR-589-5p is a potential prognostic marker of hepatocellular carcinoma and regulates tumor cell growth by targeting MIG-6.
Xu M; Wang Y; He HT; Yang Q
Neoplasma; 2018 Sep; 65(5):753-761. PubMed ID: 30249105
[TBL] [Abstract][Full Text] [Related]
82. Intraocular miR-211 exacerbates pressure-induced cell death in retinal ganglion cells via direct repression of FRS2 signaling.
Yang J; Wang N; Luo X
Biochem Biophys Res Commun; 2018 Sep; 503(4):2984-2992. PubMed ID: 30131252
[TBL] [Abstract][Full Text] [Related]
83. Reanalysis of microRNA expression profiles identifies novel biomarkers for hepatocellular carcinoma prognosis.
Wang Z; Ding Q; Li Y; Liu Q; Wu W; Wu L; Yu H
Tumour Biol; 2016 Nov; 37(11):14779-14787. PubMed ID: 27633066
[TBL] [Abstract][Full Text] [Related]
84. LncRNA AC009022.1 enhances colorectal cancer cells proliferation, migration, and invasion by promoting ACTR3B expression via suppressing miR-497-5p.
Yu C; Zhang F
J Cell Biochem; 2020 Feb; 121(2):1934-1944. PubMed ID: 31637768
[TBL] [Abstract][Full Text] [Related]
85. miR-206 Inhibits Cell Proliferation, Migration, and Invasion by Targeting BAG3 in Human Cervical Cancer.
Wang Y; Tian Y
Oncol Res; 2018 Jul; 26(6):923-931. PubMed ID: 29295729
[TBL] [Abstract][Full Text] [Related]
86. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD
Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708
[TBL] [Abstract][Full Text] [Related]
87. Dysregulation of microRNA-106a-5p-RUNX1 axis associates with clinical progression and prognosis of osteosarcoma patients.
Chen K; Pan G
Pathol Res Pract; 2019 Dec; 215(12):152686. PubMed ID: 31711673
[TBL] [Abstract][Full Text] [Related]
88. Differentially expressed genes in giant cell tumor of bone.
Babeto E; Conceição AL; Valsechi MC; Peitl Junior P; de Campos Zuccari DA; de Lima LG; Bonilha JL; de Freitas Calmon M; Cordeiro JA; Rahal P
Virchows Arch; 2011 Apr; 458(4):467-76. PubMed ID: 21305317
[TBL] [Abstract][Full Text] [Related]
89. Single-cell RNA sequencing reveals differential expression of EGFL7 and VEGF in giant-cell tumor of bone and osteosarcoma.
Feleke M; Feng W; Song D; Li H; Rothzerg E; Wei Q; Kõks S; Wood D; Liu Y; Xu J
Exp Biol Med (Maywood); 2022 Jul; 247(14):1214-1227. PubMed ID: 35695550
[No Abstract] [Full Text] [Related]
90. Characterization of Three Novel H3F3A-mutated Giant Cell Tumor Cell Lines and Targeting of Their Wee1 Pathway.
Lübbehüsen C; Lüke J; Seeling C; Mellert K; Marienfeld R; von Baer A; Schultheiss M; Möller P; Barth TFE
Sci Rep; 2019 Apr; 9(1):6458. PubMed ID: 31015476
[TBL] [Abstract][Full Text] [Related]
91. H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone.
Amary F; Berisha F; Ye H; Gupta M; Gutteridge A; Baumhoer D; Gibbons R; Tirabosco R; O'Donnell P; Flanagan AM
Am J Surg Pathol; 2017 Aug; 41(8):1059-1068. PubMed ID: 28505000
[TBL] [Abstract][Full Text] [Related]
92. Establishment and characterization of novel patient-derived cell lines from giant cell tumor of bone.
Yoshimatsu Y; Noguchi R; Tsuchiya R; Ono T; Sin Y; Akane S; Sugaya J; Mori T; Fukushima S; Yoshida A; Kawai A; Kondo T
Hum Cell; 2021 Nov; 34(6):1899-1910. PubMed ID: 34304386
[TBL] [Abstract][Full Text] [Related]
93. Regulation of breast cancer and bone metastasis by microRNAs.
Vimalraj S; Miranda PJ; Ramyakrishna B; Selvamurugan N
Dis Markers; 2013; 35(5):369-87. PubMed ID: 24191129
[TBL] [Abstract][Full Text] [Related]
94. Establishment and characterization of the NCC-GCTB4-C1 cell line: a novel patient-derived cell line from giant cell tumor of bone.
Ono T; Noguchi R; Yoshimatsu Y; Tsuchiya R; Sin Y; Nakagawa R; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2022 Jan; 35(1):392-399. PubMed ID: 34731453
[TBL] [Abstract][Full Text] [Related]
95. p53 mutations may be involved in malignant transformation of giant cell tumor of bone through interaction with GPX1.
Okubo T; Saito T; Mitomi H; Takagi T; Torigoe T; Suehara Y; Kaneko K; Yao T
Virchows Arch; 2013 Jul; 463(1):67-77. PubMed ID: 23748877
[TBL] [Abstract][Full Text] [Related]
96. Stromal cells of giant cell tumor of bone show primary cilia in giant cell tumor of bone.
Castiella T; Iruzubieta P; Monleón E; Cardiel MJ; Gómez-Vallejo J; Monzón M; Junquera MC
Microsc Res Tech; 2022 Mar; 85(3):1065-1074. PubMed ID: 34761465
[TBL] [Abstract][Full Text] [Related]
97. Serglycin induces osteoclastogenesis and promotes tumor growth in giant cell tumor of bone.
He Y; Cheng D; Lian C; Liu Y; Luo W; Wang Y; Ma C; Wu Q; Tian P; He D; Jia Z; Lv X; Zhang X; Pan Z; Lu J; Xiao Y; Zhang P; Liang Y; Yang Q; Hu G
Cell Death Dis; 2021 Sep; 12(10):868. PubMed ID: 34556636
[TBL] [Abstract][Full Text] [Related]
98. microRNAs and bone tumours: Role of tiny molecules in the development and progression of chondrosarcoma, of giant cell tumour of bone and of Ewing's sarcoma.
Palmini G; Brandi ML
Bone; 2021 Aug; 149():115968. PubMed ID: 33892177
[TBL] [Abstract][Full Text] [Related]
99. Role and expression of FRS2 and FRS3 in prostate cancer.
Valencia T; Joseph A; Kachroo N; Darby S; Meakin S; Gnanapragasam VJ
BMC Cancer; 2011 Nov; 11():484. PubMed ID: 22078327
[TBL] [Abstract][Full Text] [Related]
100. A diagnosis of giant cell-rich tumour of bone is supported by p63 immunohistochemistry, when more than 50 % of cells is stained.
Maues De Paula A; Vasiljevic A; Giorgi R; Gomez-Brouchet A; Aubert S; Leroy X; Duval H; de Pinieux G; Bouvier C
Virchows Arch; 2014 Oct; 465(4):487-94. PubMed ID: 25100342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
